selenic acid has been researched along with Frontotemporal Dementia in 1 studies
Selenic Acid: A strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.
Frontotemporal Dementia: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder often neuropathologically associated with the accumulation of abnormally hyperphosphorylated tau, for which there is currently no disease-modifying treatment." | 2.94 | A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. ( Ahmed, RM; Brodtmann, A; Bush, AI; Churilov, L; Darby, D; Hovens, CM; Kalincik, T; Malpas, CB; O'Brien, TJ; Piguet, O; Velakoulis, D; Vivash, L; Walterfang, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vivash, L | 1 |
| Malpas, CB | 1 |
| Churilov, L | 1 |
| Walterfang, M | 1 |
| Brodtmann, A | 1 |
| Piguet, O | 1 |
| Ahmed, RM | 1 |
| Bush, AI | 1 |
| Hovens, CM | 1 |
| Kalincik, T | 1 |
| Darby, D | 1 |
| Velakoulis, D | 1 |
| O'Brien, TJ | 1 |
1 trial available for selenic acid and Frontotemporal Dementia
| Article | Year |
|---|---|
A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia.
Topics: Australia; Clinical Trials, Phase II as Topic; Double-Blind Method; Frontotemporal Dementia; Humans; | 2020 |